Literature DB >> 20599609

Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.

Yuan Zhang1, Dongsheng Jiang, Junhong Zhang, Fen Wang, Xinghong Jiang, Jin Tao.   

Abstract

Neuromedin U (NMU) plays very important roles in the central nervous system. However, to date, any role of NMU in hippocampal neurons and the relevant mechanisms still remain unknown. In the present study, we report that NMU selectively inhibits L-type high-voltage-gated Ca(2+) channels (HVGCC) in mouse hippocampal neurons, in which NMU type 1 receptor (NMUR1), but not NMUR2, is endogenously expressed. In wild type mice, NMU (0.1 microM) reversibly inhibited HVGCC barium currents (I(Ba)) by approximately 28%, while in NMUR1(-/-) mice NMU had no significant effects. Intracellular infusion of GDP-beta-S or a selective antibody raised against the G(o)alpha, as well as pretreatment of the neurons with pertussis toxin, blocked the inhibitory effects of NMU, indicating the involvement of G(o)-protein. This NMUR1-mediated effect did not display the characteristics of a direct interaction between G-protein betagamma subunit (G(betagamma)) and L-type HVGCC, but was abolished by dialyzing cells with QEHA peptide or an antibody to the G(beta). The classical and novel protein kinase C (PKC) antagonist calphostin C, as well as phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002, abolished NMU responses, whereas the classical PKC antagonist Gö6976 had no such effects. Cells dialyzed with a PKC epsilon isoform (PKCepsilon) specific inhibitor peptide, GAVSLLPT, abolished NMU responses. In contrast, in cells dialyzed with an inactive PKCepsilon control scramble peptide, LSGTLPAV, no significant effects were observed. In summary, these results suggest that NMU inhibits L-type HVGCC via activation of NMUR1 and downstream G(betagamma), PI3K, and a novel PKCepsilon signaling pathway. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599609     DOI: 10.1016/j.cellsig.2010.06.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat.

Authors:  A A Rahman; I Z Shahid; P M Pilowsky
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 2.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

3.  Neuromedin U type 1 receptor stimulation of A-type K+ current requires the βγ subunits of Go protein, protein kinase A, and extracellular signal-regulated kinase 1/2 (ERK1/2) in sensory neurons.

Authors:  Yiming Zhang; Dongsheng Jiang; Yuan Zhang; Xinghong Jiang; Fen Wang; Jin Tao
Journal:  J Biol Chem       Date:  2012-04-04       Impact factor: 5.157

4.  Urotensin-II receptor stimulation of cardiac L-type Ca2+ channels requires the βγ subunits of Gi/o-protein and phosphatidylinositol 3-kinase-dependent protein kinase C β1 isoform.

Authors:  Yuan Zhang; Jiaoqian Ying; Dongsheng Jiang; Zhigang Chang; Hua Li; Guoqiang Zhang; Shan Gong; Xinghong Jiang; Jin Tao
Journal:  J Biol Chem       Date:  2015-02-12       Impact factor: 5.157

5.  Knockdown of miR-1275 protects against cardiomyocytes injury through promoting neuromedin U type 1 receptor.

Authors:  Zhu Zeng; Haixin Ma; Jing Chen; Nina Huang; Yudan Zhang; Yufei Su; Huifang Zhang
Journal:  Cell Cycle       Date:  2020-12-15       Impact factor: 4.534

6.  Phosphorylation of NR2B NMDA subunits by protein kinase C in arcuate nucleus contributes to inflammatory pain in rats.

Authors:  Fan Bu; Huiyu Tian; Shan Gong; Qi Zhu; Guang-Yin Xu; Jin Tao; Xinghong Jiang
Journal:  Sci Rep       Date:  2015-10-30       Impact factor: 4.379

7.  Cholecystokinin type B receptor-mediated inhibition of A-type K+ channels enhances sensory neuronal excitability through the phosphatidylinositol 3-kinase and c-Src-dependent JNK pathway.

Authors:  Shumin Yu; Yuan Zhang; Xianyang Zhao; Zhigang Chang; Yuan Wei; Yufang Sun; Dongsheng Jiang; Xinghong Jiang; Jin Tao
Journal:  Cell Commun Signal       Date:  2019-06-18       Impact factor: 5.712

8.  Neuromedin U uses Gαi2 and Gαo to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic β cells.

Authors:  Weidong Zhang; Hideyuki Sakoda; Yuki Nakazato; Md Nurul Islam; François Pattou; Julie Kerr-Conte; Masamitsu Nakazato
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.